Model
Edge
Lineage Cell Therapeutics
0001822933
Filing Type
4
Filing Date
7/2/2023
Updated
7/3/23, 11:45 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership